Orihuela-Rodríguez O, Carmona-Ruiz H

Language: Spanish
References: 24
Page: 254-257
PDF size: 203.43 Kb.

ABSTRACT

Introduction: The presence of 50 mL of fluid or more in the pericardial sac is known as pericardial effusion. Objective: To determine the prevalence of pericardial effusion in patients with systemic diseases. Method: Echocardiographic studies performed at the National Medical Center Siglo XXI Specialty Hospital Cardiology Department between 2006 and 2016 were reviewed. According to Weitzman’s criteria, pericardial effusion was classified as mild, ‹ 10 mm, moderate, 10 to 20 mm and severe, › 20 mm. Results: In total, 10,653 studies were reviewed; the prevalence of pericardial effusion was 3.5 % (380), in 209 women (55 %, 45.9 ± 19.0 years) and 171 men (45 %, 41.9 ± 18.5 years). Etiology was uremic in 227 (59.7 %), lymphatic drainage reduction in 73 (15.8 %), autoimmune diseases in 30 (7.9 %), neoplastic in 26 (6.8 %), infectious in 19 (5 %), idiopathic in 14 (3.7 %), hypothyroidism in two (0.5 %), iatrogenic in one (0.3 %) and post-infarction in one (0.3 %). Severity was mild in 87 (22.9 %), moderate in 147 (38.7 %) and severe in 146 (38.4 %). Conclusions: The prevalence of pericardial effusion was 3.5% in patients with systemic diseases.

REFERENCES

1. Mann DL, Zipes DP, Libby P, Bonow RO. Braunwald’s heartdisease: a textbook of cardiovascular medicine. EE. UU.: Saunders; 2000.

2. Vakamudi S, Ho N, Cremer PC. Pericardial effusions: causes, diagnosis, and management. Prog Cardiovasc Dis. 2017;59:380-388.

3. Imazio M, Gaita F, LeWinter M. Evaluation and treatment of pericarditis: a systematic review erratum. JAMA. 2015;314:1498-1506.

4. Mayosi BM, Wiysonge CS, Ntsekhe M, Gumedze F, Volmink JA, Maartens G, et al. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J. 2008;98:36-40.

5. Gornik HI, Gerhard-Herman M, Beckman JA. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol. 2005;23:5211-5216.

6. Imazio M, Hoit BD. Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol. 2013; 168(2): 648-52.

7. Rosenbaum E, Krebs E, Cohen M, Tiliakos A, Derk CT. The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review. Lupus. 2009;18:608-612.

8. Corrao S, Messina S, Pistone G, Calvo L, Scaglione R, Licata G. Heart involvement in rheumatoid arthritis: systematic review and meta-analysis. Int J Cardiol. 2013;167:2031-2038.

9. Sadjadi SA, Mashahdian A. Uremic pericarditis: a report of 30 cases and review of the literature. Am J Case Rep. 2015;16:169-173.

10. Burazor I, Imazio M, Markel G, Adler Y. Malignant pericardial effusion. Cardiology. 2013;124:224-232.

11. Dattilo G, Crosca S, Tavella S, Marte F, Patanè S. Pericardial effusion associated with subclinical hypothyroidism. Int J Cardiol. 2009; 153:e47-e50.

12. Tatekoshi Y, Yuda S, Ogasawara M, Muranaka A, Kokubu N, Hase M, et al. Successful diagnosis of pericardial rupture caused by blunt chest trauma using contrast ultrasonography. 2016;43:95-98.

13. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1-39.

14. Klein AL, Abbara S, Agles DA, Appleton CP, Asher CR, Hoit B, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013;26:965-1012.

15. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio. Rev Esp Cardiol. 2015;68:1126.e1-e64.

16. Serhan M, Abdallah R, Atar S. Characteristics of large pericardial effusion in a well-defined geographical region. Harefuah. 2017;156:311-314.

17. Méndez-Durán A, Méndez-Bueno F, Tapia-Yáñez T, Muñoz-Montes A, Aguilar-Sánchez L. Epidemiología de la insuficiencia renal crónica en México. Dial Traspl. 2010; 31(1): 7-11.

18. Imazio M, Gaido L, Battaglia A, Gaita F. Contemporary management of pericardial effusion: practical aspects for clinical practice. Postgrad Med. 2017;129:178-186.

19. Maharaj S, Chang S. Pericardial effusions in systemic lupus erythematosus - Who is most likely to develop tamponade? Int J Cardiol. 2015;180:149-50.

20. Hwang DS, Kim SJ, Shin ES, Lee SG. The N-terminal pro-B-type natriuretic peptide as predictor of disease progression in patients with pericardial effusion. Inter J Cardiol. 2012;157:192-196.

21. García-Lledó A, García-Pérez-Velasco J, Bonilla V, Ponz V. Derrame pericárdico. Medicine. 2013;11:2559-2570.

22. Soonjae H, Ji-Young B, Tae-Wan L, In-Suk K, Kwang-Min K. Pericardial tamponade caused by massive fluid resuscitation in a patient with pericardial effusion and end-stage renal disease: a case report. Korean J Anesthesiol. 2013;65:71-76.

23. Lei H, Tong L, Zheng-Zhong H, Ying-Wu L. Acute hemorrhagic cardiac tamponade as presenting findings of transmural myocardial infarction in an adult patient. Chin Med J (Engl). 2016;129:618-619.

24. Eisenberg MJ, Oken K, Guerrero S, Saniei MA, Schiller NB. Prognostic value of echocardiography in hospitalized patients with pericardial effusion. Am J Cardiol.1992;70:934-939.